本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Sutro Biopharma Inc

15.97
+0.36502.34%
成交量:6.73萬
成交額:106.44萬
市值:2.64億
市盈率:-0.92
高:16.09
開:15.94
低:15.38
收:15.60
52周最高:43.85
52周最低:7.15
股本:1,656.72萬
流通股本:1,076.62萬
量比:0.58
換手率:0.63%
股息:- -
股息率:- -
每股收益(TTM):-17.3700
每股收益(LYR):-22.4900
淨資產收益率:-1810.01%
總資產收益率:-36.08%
市淨率:-2.56
市盈率(LYR):-0.71

資料載入中...

2024/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

重要事件披露

Form 8-K - Current report
2024/11/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/04

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/08/12

重要事件披露

Form 8-K - Current report
2024/06/10

重要事件披露

Form 8-K - Current report
2024/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/04/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/02

重要事件披露

Form 8-K - Current report
2024/04/02

重要事件披露

Form 8-K - Current report
2024/03/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/25

重要事件披露

Form 8-K - Current report
2024/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

重要事件披露

Form 8-K - Current report